Therapy-Dog Visits for Kids With Cancer: a Safe Way to Induce Smiles?
Dr. Jessica Chubak and Rene Hawkes from Kaiser Permanente Washington Health Research Institute, with Dr. Catherine Fiona Macpherson at Seattle Children’s Hospital and other collaborators just published the results of their pilot study in the Journal of Pediatric Oncology Nursing on therapy-dog visits for children hospitalized for cancer. Now, Chubak is launching a larger randomized controlled trial based on the successful pilot study. Her co-investigator is Dr. Danielle Zerr, Seattle Children's medical director of infection prevention and UW professor and division chief of pediatric infectious diseases. The Seattle Children's team for the randomized controlled trial includes Dr. Xuan Qin, Dr. Douglas Hawkins, Amanda Adler, Sarah Steele and Amin Addetia.
About Seattle Children’s
Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.
Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.
For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.